Johnson, S., P.-J. Maziade, L.V. McFarland, W. Trick, C. Donskey, B. Currie, D.E. Low, E.J.C. Goldstein. 2012. Is primary prevention of Clostridium difficile infection possible with specific probiotics? International Journal of Infectious Diseases, Epub ahead of print (22863358).
Gao, XW. et al. 2010. Dose–response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 andLactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. American Journal of Gastroenterology.
Psaradellis, F. and J. Sampalis. 2010. Efficacy of a probiotic formula in the reduction of antibiotic-associated diarrhea- a placebo controlled, double-blind randomized, multicenter study. Archives of Medical Science, 6(1):56-64.
Maziade, P-J. 2009. Efficacy of the probiotic, Bio-K+CL1285®, in the control of a nosocomial outbreak of severe Clostridium difficile-associated diarrhea at the Centre Hospitalier Pierre-Le-Gardeur: a case report.www.advin.org/en/images/stories/DOC/Maziade-Probiotic_and_C.difficile_Study.pdf
Karska-Wyzocki, B. et al. 2010. Antibacterial activity of Lactobacillus acidophilus andLactobacillus casei against methicillin-resistant Staphylococcus aureus (MRSA). Microbiological research.
Millette, M. et al. 2010. Probiotic Lactobacillus acidophilus and L. casei mix sensitize colorectal tumoral cells to 5-fluorouracil-induced apoptosis. Nutrition and Cancer. 62(3):371-8.
Millette, M. et al. 2008. Characterization of probiotic properties of Lactobacillus strains. Dairy Science and Technology.88:695-705.
Millette, M. et al. 2007. In vitro growth control of selected pathogens by Lactobacillus acidophilus- and Lactobacillus casei-fermented milk. Letters in Applied Microbiology. 44:314–319
Beausoleil, M. et al. 2007. Effect of a fermented milk combining Lactobacillus acidophilus CL1285® and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: A randomized, double-blind, placebo-controlled trial. Canadian Journal of Gastroenterology. 21:11 732-736.
Scientific studies on probiotics and others:
Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. 2012. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA. 307(18):1959-1969.
Videlock EJ, Cremonini F. 2012. Meta-analysis: probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 35(12):1355-1369.
Wolvers, D. et al. 2010. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. Journal of Nutrition. 140:698S-712S.
Rabot, S. et al. 2010. Guidance for substantiating the evidence for beneficial effects of probiotics: impact of probiotics on digestive system metabolism. Journal of Nutrition. 140:677S-689S.
Chmielewska A. and Szajewska H. 2010. Systematic review of randomized controlled trials: probiotics for functional constipation. World Journal of Gastroenterology. 16(1):69-75.
McFarland, L. 2010. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol. 16(18):2202-2220.
Sherman, PM. et al. 2009. Unraveling Mechanisms of Action of Probiotics. Nutrition and Clinical Practice. 24:10-14.
Resta, SC. 2009. Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling. Journal of Physiology. 587:4169-4174.
Sanders, ME. 2009. How Do We Know When Something Called “Probiotic” Is Really a Probiotic? A Guideline for Consumers and Health Care Professionals. Functionnal Food Review. 1:1-12.
Kurtmann, L. et al. 2009. Browning of freeze-dried probiotic bacteria cultures in relation to loss of viability during storage. Journal of Agricultural and Food Chemistry. 57:6736-6741.
Ding, WK. and NP. Shah. 2009. Effect of various encapsulating materials on the stability of probiotic bacteria. Journal of Food Science. 74:M100-M107.
Hoveyda, N. et al. 2009. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterology.9:15.
Kanauchi, O. et al. 2009. The therapeutic impact of manipulating microbiota in inflammatory bowel disease. Current Pharmaceutical Design. 15:2074-2086
Davis, CD. and JA. Milner. 2009. Gastrointestinal microflora, food components and colon cancer prevention. Journal of Nutritional Biochemistry. 20(10):743-752.
Ng, SC. et al. 2009. Mechanisms of action of probiotics: recent advances. Inflammatory Bowel Disease. 15:300-310.
Leyer, GJ. et al. 2009. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics. 124(2):e172-e179.
de Vrese, M. and J. Schrenzenmeir. 2008. Probiotics, Prebiotics, and synbiotics. Advances in Biochemical Engineering/Biotechnology. 111:1-66.
Mengheri, E. 2008. Health, probiotics, and inflammation. Journal of Clinical Gastroenterology.42 (suppl. 3):S177-178.
Linfors, K. et al. 2008. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clinical and Experimental Immunology. 152:552–558.
Pregliasco, F. et al. 2008. A new chance of preventing winter diseases by the administration of synbiotic formulations. Journal of Clinical Gastroenterology. 42 Suppl 3, Pt 2:S224-S233.
McFarland, L. 2007. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Medicine and Infectious Disease. 5:97-105.
Hedin, C. et al. 2007. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. The Proceedings of the Nutrition Society. 66:307-315.
Falagas, ME. et al. 2006. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. The Journal of Antimicrobial Chemotherapy. 58(2):266-272.
Luquet, FM. and G. Corrieu. 2005. Bactéries lactiques et probiotiques. Édition Tec et Doc, 307 pages. Yates, J. 2005. Traveller’s Diarrhea. American Family Physician. 71:2095-2100
Gerding, DN. 2004. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficle-associated diarrhea: this is an antimicrobial resistance problem. Clinical Infectious Disease. 38:646-648.
Penna, FJ. et al. 2000. Up to date clinical and experimental basis for the use of probiotics. Journal of Pediatrics.76 (suppl): 209-217.
Perdigon, G. et al. 1999. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. Journal of Dairy Science.82:1108-1114.
Fitzsimmons, N. and DR. Berry. 1994. Inhibition of Candida Albicans by Lactobacillus acidophilus: evidence for the involvement of a peroxydase system. Microbios.80:125-133